US
AbbVie’s Skyrizi snatches up FDA approval in moderate to severe plaque psoriasis
April 24, 2019Research and Development, Sales and Marketing AbbVie, FDA, Skyrizi, US, pharma, psoriasis
AbbVie has revealed that its interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab-rzaa) has received marketing authorisation in the US from the FDA …
Clovis Oncology discontinue phase 2 bladder cancer trial
April 15, 2019Sales and Marketing Cancer, Clovis Oncology, US, bladder cancer, metastatic bladder cancer
Colorado-based pharma firm Clovis Oncology has said in a filing to the US Securities and Exchange Commission that it is …
Opioid crisis cost US government nearly $38 billion in lost taxes
April 11, 2019Medical Communications, Research and Development US, government, opioid crisis, opioids, public health, tax revenue
The opioid epidemic may have cost US state and federal governments as much as $37.8 billion in lost tax revenue, …
Pharmacy Benefit Manager (PBM) execs testify before US Senate
April 10, 2019Research and Development PBMs, Rebates, Senate, US, pharma, senator, sfc
Executives representing pharmacy benefit managers (PBMs) appeared before the US Senate Finance Committee on Tuesday as they testified on the …
Novartis must face kickback allegations in court
April 2, 2019Manufacturing and Production Novartis, US, government, kickbacks, prescriptions, whistle blower, whistle-blower
The US government has accused Novartis of paying doctors millions of dollars in kickbacks as part of a “company-wide kickback …
Measles outbreak spurs New York County to ban all unvaccinated children from public spaces
March 27, 2019Research and Development New York, US, pharma, vaccination, vaccines
Rockland County, New York State, is taking serious measures to combat its biggest measles outbreak in decades, making the decision …
FDA advisory panel recommends Sanofi’s dengue vaccine in children, but rejects its use in adults
March 11, 2019Sales and Marketing FDA, Sanofi, US, Vaccine, dengue, dengvaxia, pharma
Dengvaxia, Sanofi’s vaccine for dengue fever, has been burdened with further negative scrutiny after the FDA’s vaccine advisory panel passed …
Trump ex-lawyer Cohen reveals Novartis pushed him to lobby
February 28, 2019Sales and Marketing Donald Trump, Michael Cohen, Novartis, US, pharma
Among the swirling storm emanating from the testimony of Donald Trump’s ex-lawyer Michael Cohen to the House Oversight Committee, one …
Clinigen shares soar after $210m Novartis cancer drug deal
February 13, 2019Research and Development Cancer, Clinigen, Novartis, Proleukin, UK, US, oncology
British company Clinigen has bought the rights to sell Novartis’ cancer drug Proleukin in the United States in a deal …
Stripper-turned-Insys sales rep gave lap dance to persuade doctor to prescribe fentanyl
January 31, 2019Medical Communications Sunrise Lee, US, chicago, corruption, insys, sales
A pharmaceutical executive working for Insys therapeutics has been accused of giving a doctor a lap dance in an effort …
Purdue Pharma sought to expand into opioid addiction treatments while using McKinsey to counter “emotional messages”
January 31, 2019Business Services, Medical Communications Massachusetts, OxyContin, Purdue Pharma, US, USA, opioids
OxyContin drugmaker Purdue Pharma explored expanding into the market for opioid addiction treatments, according to passages from court documents that …
J&J joins in on industry price hiking; almost 500 drug prices increased in 2019 so far
January 11, 2019Medical Communications, Sales and Marketing J&J, JJ, Stelara, US, Xarelto, Zytiga, pharma, price hikes
It’s only the second week of the New Year, and Johnson & Johnson has announced plans to hike the prices …
AstraZeneca to shut down twin Colorado manufacturing sites, impacting over 200 jobs
January 10, 2019Manufacturing and Production AstraZeneca, US, job cuts, pharma
UK-based drug firm AstraZeneca has revealed it is set to shed more than 200 positions from its operations at two …
Generics firms investigated for their involvement in the ‘largest cartel in the history of the United States’
December 11, 2018Manufacturing and Production Dr Reddy's, Mylan, Teva, US, corruption, generics, price fixing, price-fixing, sun
At least 16 generic drugmakers are being investigated for their involvement in what has been described as the “largest cartel …
Working Life: Kai Gait, Senior Global Digital Director at GlaxoSmithKline
December 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, GSK, Interview, UK, US, digital, senior global director, technology
Kai Gait, Senior Global Digital Director at GlaxoSmithKline, retraces the steps that have led him to where he is today, …
Latest content
FibroFind appoints Lee Borthwick as CEO
